home / stock / esalf / esalf short
Short Information | Eisai Co Ltd (OTCMKTS:ESALF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,797 |
Total Actual Volume | 13,022 |
Short Trends | |
---|---|
Cover Days | 6 |
Short Days | 13 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 190 |
Average Short Percentage | 58.67% |
Is there a ESALF Short Squeeze or Breakout about to happen?
See the ESALF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-19-2024 | $38.79 | $38.95 | $38.95 | $38.79 | 925 | 500 | 54.05% |
04-18-2024 | $38.1 | $37.53 | $38.1 | $37.53 | 2,125 | 383 | 18.02% |
04-17-2024 | $38.18 | $38.11 | $38.18 | $38.11 | 899 | 31 | 3.45% |
04-15-2024 | $0 | $39 | $0 | $0 | 37 | 37 | 100% |
04-12-2024 | $0 | $39 | $0 | $0 | 90 | 49 | 54.44% |
04-11-2024 | $39 | $39 | $39 | $39 | 120 | 120 | 100% |
04-10-2024 | $39.19 | $39.2 | $39.2 | $38.59 | 2,260 | 160 | 7.08% |
04-09-2024 | $0 | $40.375 | $0 | $0 | 43 | 43 | 100% |
04-04-2024 | $40.31 | $40.3 | $40.31 | $39.15 | 750 | 500 | 66.67% |
04-03-2024 | $39.88 | $39.88 | $39.88 | $39.88 | 1,630 | 310 | 19.02% |
04-01-2024 | $40.135 | $40.135 | $40.135 | $40.135 | 320 | 309 | 96.56% |
03-28-2024 | $42.33 | $41.682 | $42.33 | $41.225 | 392 | 192 | 48.98% |
03-27-2024 | $42.35 | $42.35 | $42.35 | $42.35 | 670 | 500 | 74.63% |
03-25-2024 | $42.3 | $42.3 | $42.3 | $42.3 | 935 | 5 | 0.53% |
03-22-2024 | $42.195 | $42.185 | $42.195 | $42.185 | 1,240 | 209 | 16.85% |
03-21-2024 | $0 | $42 | $0 | $0 | 44 | 44 | 100% |
03-20-2024 | $42 | $42 | $42 | $42 | 110 | 100 | 90.91% |
03-18-2024 | $43.89 | $43.15 | $43.89 | $43.15 | 200 | 100 | 50% |
03-15-2024 | $43.88 | $43.88 | $43.88 | $43.88 | 135 | 135 | 100% |
03-14-2024 | $0 | $44.02 | $0 | $0 | 97 | 70 | 72.16% |
News, Short Squeeze, Breakout and More Instantly...
Eisai Co Ltd Company Name:
ESALF Stock Symbol:
OTCMKTS Market:
Eisai: Research on Treatments for Alzheimer's Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category) TOKYO, Apr 18, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that "The Research on Treatments for Alzheimer's Disease Ba...
Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan TOKYO, Apr 17, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that the injection formulation of its in-house discovered antiepileptic drug (AED) Fycompa (perampanel hydrate) for intravenous (IV) infu...
French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics TOKYO, Apr 3, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that its French sales subsidiary Eisai S.A.S. entered into an agreement to transfer the rights in France, the ...